Month: July 2024

WOODCLIFF LAKE, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Tuesday, August 6, 2024 at 5:00 p.m. Eastern Time to discuss the Company’s second quarter 2024 results. To access the live webcast, log onto the Hudson Technologies website at www.hudsontech.com, and click on “Events”. To participate in the call by phone, dial (877) 545-0523 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0016. Callers should use entry code: 384150. A replay of the teleconference will be available until September 5, 2024 and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 50910. About Hudson Technologies Hudson Technologies, Inc. is a leading...

ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Novitas Solutions, Inc. (Novitas), a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the Company’s CompuFlo® Epidural System under the American Medical Association’s (AMA) technology-specific Category III CPT® code CPT0777T (real-time pressure-sensing epidural guidance system when used in conjunction with a primary ESI procedure). This new price assignment applies to two Medicare regions: Jurisdiction L (JL) and Jurisdiction H (JH). JL includes Delaware, District of Columbia, Maryland, New Jersey, and Pennsylvania. JH includes Arkansas, Colorado, Louisiana,...

Patient dosing in the second cohort has commenced following the successful completion of the first cohort GLEN ALLEN, Va., July 23, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the progression to the second cohort in the pharmacokinetics study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients (defined as < 10 drinks/drinking day), following the successful completion of the first cohort. Topline results from both cohorts are expected to be announced during the fourth quarter of 2024. Cary...

DENVER, July 23, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports treatment of the first patient in a commercial setting with QUELIMMUNE™, its U.S. Food and Drug Administration (FDA)-approved, patented cell-directed extracorporeal therapy to treat acute kidney injury (AKI) in pediatric patients weighing 10 kilograms or greater with sepsis or a septic condition requiring kidney replacement therapy (KRT). With this development, the Company has now met the August 20, 2024 FDA deadline to begin patient treatments, which is designated in the FDA’s approval of QUELIMMUNE. “This commercial milestone is highly gratifying to the SeaStar Medical team that has worked so hard to make QUELIMMUNE available to patients in need. Results from completed clinical trials show the potential...

Current FactSet Executive Goran Skoko to Take on Role of Chief Revenue Officer Company Reaffirms Full-Year Fiscal 2024 Guidance NORWALK, Conn., July 23, 2024 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, today announced that Helen Shan, a seasoned FactSet executive who currently serves as Executive Vice President and Chief Revenue Officer, has been appointed Chief Financial Officer, effective immediately. Shan succeeds Linda Huber, who is transitioning out of the Company. Shan brings extensive financial leadership experience and business expertise within FactSet, and is rotating back into the CFO role, which she previously held from 2018 to 2021 before being appointed Executive Vice President and Chief Revenue Officer. As CFO,...

VANCOUVER, British Colombia, July 23, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG, OTCQX: BBKCF, WKN: A2PS9W) is an established, diverse and innovative company operating globally in the Digital Asset, Blockchain and Metaverse sectors: Netcoins (Netcoins.com), Blockchain Intelligence Group (BlockchainGroup.io), and TerraZero (TerraZero.com). Blockchain Intelligence Group announces the launch of new CCI modules:Module 9 – Hacks & Exploits Module 10 – Compliance & Risk Management (Standalone Certification) Certified Cryptocurrency Investigator – Advanced Series (CCI-A)Blockchain Intelligence Group (BIG), a global leader in cryptocurrency investigations and compliance solutions, announces the launch of two new advanced modules for its acclaimed Certified Cryptocurrency...

TORONTO, July 23, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production, and distribution of high-quality, low latency hologram and digital content, is set to return with a dynamic interactive hologram experience at the prestigious 3M Open from July 22-28th, a highlight on the PGA Tour calendar held annually at TPC Twin Cities in Blaine, Minnesota. After a successful debut at the 3M Open in 2023, ARHT CAPSULE returns to the PGA Tour, showcasing its innovative capabilities to educate and engage attendees. The event will feature 360° interactive virtual content on the holographic display, challenging attendees to find and interact with numerous 3M products within two virtual locations: a golf course and homes, illustrating...

BEIJING, July 23, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification from the Nasdaq Stock Market LLC (“Nasdaq”) on July 18, 2024, informing the Company that it has regained compliance with Nasdaq’s periodic filing requirement set forth under Listing Rule 5250(c)(1), because the Company had filed its annual report on Form 20-F for the period ended October 31, 2023 on July 17, 2024. About TIAN RUIXIANG Holdings Ltd TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products,...

Figure 1The Annular Linear Induction Pump (ALIP) technology SBIR Phase III Program previously DOE funded $1.37Million in grants to support technology is led by Renowned Physicist and Carlos O. Maidana, Ph.D.The Annular Linear Induction Pump (ALIP) is a key enabling technology for NANO Nuclear’s ‘ODIN’ microreactor in development and the broader advanced nuclear reactor industry. New York, N.Y., July 23, 2024 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear”), a vertically integrated advanced nuclear energy and technology company developing portable clean energy solutions, today announced that it has filed a series of provisional patent applications with the United States Patent and Trademark Office (USPTO) to secure intellectual property rights for its recently acquired enabling annular linear induction...

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to $19.5 million in Q3 2024 from $15.9 million in Q3 2023, a $3.6 million or 22.6% increase. Delivered a thirteenth consecutive quarter of positive Adjusted EBITDA1 of $2.8 million. All financial results are reported in Canadian dollars, unless otherwise stated. MONTREAL, July 23, 2024 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced its fiscal third quarter...